Services for Researchers

Collaborative Antiviral Study Group (CASG)

Application Process

• A description of the overall study, including the unmet medical need(s) to be addressed by the study and, for example, how data obtained via these contract resources will support the development of therapies for the viral disease of concern (e.g. pharmacokinetic data to determine appropriate dosing of a drug in a special population).
• Background and significance including, for example, a concise scientific justification for the proposed study. The justification should address the potential impact of the study on treatments and/or medical management of the disease to be studied.
• Preliminary data that support the request to conduct the proposed study. Examples include: a summary of available safety data (i.e. toxicology data and previous human experience); drug disposition data (i.e. pharmacokinetics and metabolism); and/or information on feasibility of outcome measures.
• A list of other governmental and non-governmental funded and pending support and a brief description of activities relevant to the request.
• Description of the overall plan for advancing the product beyond completion of the services requested, if appropriate.